Advertisement
Canada markets closed
  • S&P/TSX

    24,471.17
    +168.87 (+0.69%)
     
  • S&P 500

    5,815.03
    +34.98 (+0.61%)
     
  • DOW

    42,863.86
    +409.76 (+0.97%)
     
  • CAD/USD

    0.7259
    -0.0010 (-0.14%)
     
  • CRUDE OIL

    74.79
    -0.77 (-1.02%)
     
  • Bitcoin CAD

    88,594.77
    +2,183.04 (+2.53%)
     
  • XRP CAD

    0.74
    +0.00 (+0.45%)
     
  • GOLD FUTURES

    2,672.70
    -3.60 (-0.13%)
     
  • RUSSELL 2000

    2,234.41
    +45.99 (+2.10%)
     
  • 10-Yr Bond

    4.0730
    -0.0230 (-0.56%)
     
  • NASDAQ futures

    20,407.25
    -42.75 (-0.21%)
     
  • VOLATILITY

    20.46
    -0.47 (-2.25%)
     
  • FTSE

    8,253.65
    +15.92 (+0.19%)
     
  • NIKKEI 225

    39,605.80
    +224.90 (+0.57%)
     
  • CAD/EUR

    0.6642
    0.0000 (0.00%)
     

Stocks in play: Resverlogix Corp.

Has entered into definitive transaction documents for the two-year extension of the Company's US$6.0 million secured convertible debenture with Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (and payment of accrued interest thereon), extending the maturity date to May 13, 2026. Resverlogix Corp. shares T.RVX are trading unchanged at $0.05.

Read: